Question 1

Does Charles Schwab Investment Management own LYEL stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Charles Schwab Investment Management holds 107,570 shares of LYEL (Lyell Immunopharma), worth $1.5M.

Question 2

How many shares of LYEL does Charles Schwab Investment Management own?

Accepted Answer

As of its Q2 2026 13F, Charles Schwab Investment Management holds 107,570 shares of LYEL (Lyell Immunopharma).

Question 3

What is Charles Schwab Investment Management's LYEL position worth?

Accepted Answer

As of its Q2 2026 13F, Charles Schwab Investment Management's LYEL position is worth $1.5M.

Question 4

Is Charles Schwab Investment Management buying or selling LYEL?

Accepted Answer

In Q2 2026, Charles Schwab Investment Management increased its LYEL position by 21,599 shares (+25.1%).

Question 5

When did Charles Schwab Investment Management first buy LYEL?

Accepted Answer

Charles Schwab Investment Management already held LYEL in its Q2 2025 13F, the earliest on record, and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	107,570	+25.1%	$1.5M	0.0%	$14.05	31
2026-Q1	Increased	85,971	+0.6%	$1.7M	0.0%	$23.33	26
2025-Q4	Increased	85,423	+7.4%	$2.6M	0.0%	$31.59	28
2025-Q3	Increased	79,510	+29.3%	$1.3M	0.0%	$14.97	32
2025-Q2	New	61,503	-	$543,687	0.0%	$8.94	34

LYEL5 quarters

LYEL
5 quarters